Ms. Underwood (for herself, Ms. Schakowsky, Mr. Guthrie, Mr. Kelly of Pennsylvania, and Mr. Levin of Michigan) introduced the following bill; which was referred to the Committee on Energy and Commerce
To amend the Biologics Price Competition and Innovation Act of 2009 to streamline the transition of certain products from approval as a drug to licensure as a biological product, and for other purposes.
Citations are generated automatically from bibliographic data
as a convenience and may not be complete or accurate.
Chicago
U.S. Congress. House. Lower Insulin Costs Now Act. H.R. 5444. 116th
Cong., 1st
sess., Introduced in House December 17, 2019. https://www.govinfo.gov/app/details/BILLS-116hr5444ih.
APA
Congress, House of Representatives (2019, December 17). Lower Insulin Costs Now Act (H.R. 5444 (IH)). Retrieved from https://www.govinfo.gov/app/details/BILLS-116hr5444ih.
MLA
United States, Congress, House of Representatives. Lower Insulin Costs Now Act. U.S. Government Publishing Office, https://www.govinfo.gov/app/details/BILLS-116hr5444ih. 116th Congress, H.R. 5444, Introduced in House 17 Dec. 2019.
Bluebook
H.R.5444 - 116th Congress (2019-2020): Lower Insulin Costs Now Act, H.R.5444, 116th Cong. (2019), https://www.govinfo.gov/app/details/BILLS-116hr5444ih.
